Postes actifs de Maureen Deehan
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Vivtex Corp. | Directeur Général | 21/02/2023 | - |
| Directeur des opérations | 01/12/2022 | 21/02/2023 |
Historique de carrière de Maureen Deehan
Anciens postes connus de Maureen Deehan
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| THOR MEDICAL | Corporate Officer/Principal | 01/06/2018 | - |
Formation de Maureen Deehan
| University of Glasgow School of Medicine | Doctorate Degree |
| University of Strathclyde | Undergraduate Degree |
Statistiques
Internationale
| Royaume-Uni | 3 |
| Norvège | 2 |
| Etats-Unis | 2 |
Opérationnelle
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Consumer Services | 3 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Nordic Nanovector ASA
 Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Nordic Nanovector ASA is a biopharmaceutical company, which engages in the development, marketing, and sale of medical products and equipment for anticancer therapeutics for haematological cancers. The firm offers the Betalutin which is an antibody radionuclide conjugates for the treatment of non-Hodgkin lymphoma. It operates through the following geographical segments: Norway, Switzerland, and the United Kingdom. The company was founded by Roy Hartvig Larsen, Oyvind Sverre Bruland, and Jostein Dahle on July 2, 2009 and is headquartered in Oslo, Norway. | Health Technology |
| Vivtex Corp. |
- Bourse
- Insiders
- Maureen Deehan
- Expérience
